What is Geron's remainder of fiscal year 2024?

Geron (GERN) reported remainder of fiscal year 2024 of $11.93M in Q1 2026.

Geron GERN Remainder of Fiscal Year 2024

Remainder of Fiscal Year 2024 at other companies

Jazz PharmaceuticalsJAZZ

——

BiogenBIIB

——

Other financials

Income statement

See full

Revenue$51.8M+30.9%

Operating income$158.0K+101%

Net income-$3.6M+81.6%

EPS (diluted)-$0.01+66.7%

Balance sheet

See full

Cash & equivalents$48.7M-12.2%

Total debt$134.0M+10.0%

Total equity$229.1M-14.6%

Total assets$534.1M-5.0%

Cash flow

See full

Operating cash flow-$62.9M-31.1%

CapEx$206.0K+2.0%

Free cash flow-$43.8M-6.8%

Valuation

See full

Market cap$878.88M-8.6%

Enterprise value$964.15M-6.2%

P/S4.7×-172×

Profitability

See full

Operating margin-705.5%-351pp

Net margin-682.5%-339pp

FCF margin-734.4%-365pp

Returns & leverage

See full

Return on equity-27.1%-7.8pp

Debt / equity0.6×+0.1×

Current ratio6.8×-1.1×

Where this comes from

Reported directly by Geron in its filing.

Tagged under the XBRL concept us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear.

The official record: Geron’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Geron's remainder of fiscal year 2024.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Geron's remainder of fiscal year 2024?: Geron (GERN) reported remainder of fiscal year 2024 of $11.93M in Q1 2026.